The production of various eremophilane-type sesquiterpenes by Penicillium roqueforti strains has allowed us to propose a biochemical pathway for PR toxin synthesis. A time-course study of P. roqueforti metabolite production by highperformance liquid chromatography was performed to check this hypothetical pathway. The results obtained suggested that eremofortin C was the direct precursor of PR toxin in the P. roqueforti cell. Attempts to determine the amount of PR toxin in the mycelium failed. It was shown that the absence of PR toxin in mycelium was due to its instability during the extraction procedure.
The production of various eremophilane-type sesquiterpenes by Penicillium roqueforti strains has allowed us to propose a biochemical pathway for PR toxin synthesis. A time-course study of P. roqueforti metabolite production by highperformance liquid chromatography was performed to check this hypothetical pathway. The results obtained suggested that eremofortin C was the direct precursor of PR toxin in the P. roqueforti cell. Attempts to determine the amount of PR toxin in the mycelium failed. It was shown that the absence of PR toxin in mycelium was due to its instability during the extraction procedure.
Penicillium roqueforti is a fungal species used in the ripening of French Roquefort cheese and also commonly found in fermenting silage (10) . Numerous secondary metabolites have been isolated from this species including the alkaloids roquefortine and isofumigaclavine A (9, 13) , and terpenoid compounds such as PR toxin and closely related compounds, including eremofortins A, B, C, and D (EA, EB, EC, and ED, respectively) (5, 6, 14) . PR toxin (PRT) is the only toxic compound among these terpenoid metabolites (1, 8) .
The aldehyde group of the molecule has been shown to be directly involved in the biological and biochemical activity of PRT (8) .
Nothing is known about the biosynthesis of PRT by P. roqueforti. We report here a first attempt to understand the biochemical pathway used by P. roqueforti for PRT production. The production of PRT and related eremofortin metabolites was quantitatively studied throughout the growth cycle of P. roqueforti. This study allowed us to propose a pathway for PRT biosynthesis.
MATERIALS AND METHODS
Organisms. Two strains were used for PRT production: the NRRL 849 strain commonly used for PRT determination, and a B strain isolated from French blue cheese and used for the production of EA, EB, EC, ED, and PRT. Each strain was cloned before the experiments, and the cultures were maintained on potato dextrose agar slants.
Medium. The basal medium consisted of 2% yeast extract (Difco) and 15% sucrose in demineralized water. The medium was sterilized by filtration on membrane filters (0.2 ,um; Millipore Corp.).
Cultures. The cultures were maintained in 800-ml Roux bottles containing 150 ml of medium. Each was inoculated with about 106 to 108 spores of P. roqueforti washed from potato dextrose agar slants. The Roux bottles were incubated as stationary cultures in the dark at 250C.
Extraction. On a given day, three bottles were chosen and submitted to the following operations. The culture was filtered, and the mycelium was carefully washed with demineralized water. The mycelium was desiccated in a 1100C oven until a constant weight was measured. For metabolite determination in mycelium, the three mycelial mats of one day were gathered, blended with 100 ml of water for 1 min at high speed in a Waring blender, and then extracted with 200 ml of chloroform for 1 h in a shaking agitator. The chloroform phase was collected and evaporated to dryness.
The media of the three bottles were gathered and extracted three times with 300 ml of chloroform. The chloroform phases were collected and evaporated to dryness.
Analysis. The crude mycelium and medium extract were purified separately before high-performance liquid chromatography (HPLC) analysis. They were chromatographed on a short column of silica gel (Merck) (0.6 cm ID by 7 cm long) and eluted with 10 ml of chloroform-methanol (98:2, vol/vol). The elution solvent was evaporated, and the purified extract was submitted to HPLC analysis as described in a previous paper. HPLC separations were carried out with a Waters Associates ALC 204 instrument equipped with a M-6000 A pump, a U 6 K injector, and a model 440 absorbance detector (0.005 to 2 absorbance units, full scale) with a 254-nm filter. Chromatograms were recorded on an Omniscribe 10-in. recorder (Houston Instruments). A Microporasil 10-,um silica gel column (4 mm ID by 30 cm long) was used (7) .
EA, EB, and PRT were analyzed with the following solvent system: n-hexane and tetrahydrofuran (75:25, vol/vol) (Solvent; Documentation Synthese, Valdonne, France) at a flow rate of 1.5 ml/min. EC was analyzed with a second solvent system: chloroform (Merck) at a flow rate of 2 ml/min. All solvents were of analytical grade. Crude extracts were diluted, and 10 ,ul of each dilution was injected onto the HPLC apparatus. Quantitation was obtained by peak height measurements and comparison with standards.
RESULTS
The time-course study of metabolite production was first attempted on the B strain, which is able to produce all the known sesquiterpene metabolites of P. roqueforti. The experiment was conducted over a 25-day period. Three Roux bottles were analyzed at chosen dates, and in this first experiment the dry mycelium weight, pH of medium, and content of medium were simultaneously determined. Dry mycelium weight as measured here is the mean of the weight of three mycelial mats. The pH of the media of the three bottles was measured just before extraction. The media of the three Roux bottles were combined and then extracted with chloroform. The crude extract thus obtained was then chromatographed on a short silica gel column by elution with 10 ml of chloroform-methanol (98:2, vol/vol). This chromatography was necessary to eliminate the more polar compounds which could contaminate the HPLC column. Thin-layer chromatography showed that this solvent eluted all the desired metabolites of P. roqueforti. The HPLC method for P. roqueforti metabolites was described in a previous paper (6) . The metabolites analyzed here are those having the a,/3-unsaturated ketone groups which allow a detection by ultraviolet absorption at 254 nm, namely, EA, EB, EC, and PRT.
Typical chromatograms of the extract of medium B are shown in Fig. 1 . Figure 2 shows the amount of the various metabolites as a function of time. PRT in the medium peaked at 11 mg per Roux-bottle culture at 10 days. The variation of the pH was slight, from 6.7 to 5.1 at 21 days. The production of metabolites occurred before complete growth of the mycelium. The experiment was repeated three times, and the typical pattern observed was reproducible. The only characteristic feature was that the maximum of EC always preceded that of PRT. The lowering of the amount of EC in the medium was always associated with an increasing amount of PRT.
In a second series of experiments we performed a time-course study on an NRRL 849 strain which was able to accumulate EC, PRT, and ED. We analyzed here EC and PRT (Fig.  3) . The pattern observed here agrees well with the preceding one. The maximum amount of EC always preceded that of PRT during the timecourse study.
In a third set of experiments, we studied the occurrence of these metabolites in the mycelium of various strains. Using the NRRL 849 strain,
we filtered the contents of three Roux bottles on a given day and extracted the mycelium mat as described in Materials and Methods. The HPLC analysis of various extracts did not show the presence of PRT. The extracts were controlled by thin-layer chromatography. The characteristic green fluorescence of PRT was sometimes detected but was very weak (12) . In all these experiments the amount of PRT in the medium was the same as that found in the preceding experiments. The extraction method was then modified. The mycelium was ground with glass powder (broken cells were examined by microscopy) and then extracted by the usual method. This did not allow any recovery of PRT. The same methods were applied with the B strain. Table 1 shows the results obtained on a given day for medium and mycelium. It is interesting that all the metabolites were found in the mycelium except PRT, as shown by the typical chromatogram in Fig. 4 . A last series of experiments was performed to determine the loss of PRT during the procedure of analysis. A mycelium from NRRL 849 was collected at 14 days and divided into two equal portions. The first was treated as described in Materials and Methods. To the second was added 0.2 mg of PRT and EA just before the extraction procedure. The two extracts were than analyzed by HPLC. The first extract did not show any detectable amount of PRT. In the second one 15% of the added PRT and 45% of the EA were recovered. The same experiment, repeated with 0.5 mg of PRT and EA, gave comparable results: 11% of PRT recovered and 40% of EA.
DISCUSSION
Mycotoxins as well as numerous naturally occurring compounds belong to the pool of secondary metabolites. Secondary metabolic pathways use compounds which originate during primary metabolism and are then metabolized by enzymes associated with secondary metabolism (4). The metabolic reactions generally lead to a more oxidized skeleton than the former compound.
As can be shown by biosynthetic experiments using sodium acetate (labeled with carbon- 13) as precursor, PRT is a terpenoid compound (S.
Moreau, unpublished data). The carbon skeleton of this molecule is an eremophilane type (2). EA, EB, EC, ED, and PRT are derived from the same basic skeleton. This skeleton arises from a particular cyclization of farnesyl pyrophosphate, followed by a suitable rearrangement.
Structural differences in closely related compounds can serve as a basis for hypotheses conceming biosynthetic pathways. Our previous work on the metabolization of PRT and EA by rat liver enzymes (9) has shown interesting transformations in this series. A hydroxylation reaction of EA leading to EC was found. All these data allowed us to propose a hypothetical biosynthetic pathway for P. roqueforti metabolites (Fig. 5) .
In this hypothesis EC is the direct precursor of two compounds: the oxidation of OH group on C-12 results in PRT, and the reduction of the 9, 10 double bond leads to ED. EA is the direct precursor of EC by a single hydroxylation reaction on C-12. Several steps are necessary to transform EB into EA.
Does the time-course study help us to prove or disprove such a scheme? It is a known fact that the early compounds in any metabolic sequence are formed first chronologically, and in theory sequential analysis should detect the order in which they appear (3).
The stability of the amounts of EB and EA during the time did not show that these compounds could be precursors of EC, PRT, and ED. Nevertheless, this time-course study revealed an interesting fact. The peak amount of EC occurred earlier than that of PRT, whatever the strain used. The decrease in the amount of EC was always associated with a rapid increase in PRT production. This point led us to think that in vivo EC could be the direct precursor of PRT. The enzymes responsible for such conversions are alcohol dehydrogenases catalyzing the reversible interconversion alcohol ketone. Our experiments on in vitro conversion of rat liver enzymes showed that the reduction step could occur. It is probable that in vivo in the This time-course study is a first step in the elucidation of the PRT biosynthetic pathway used by P. roqueforti. The conclusion we can draw from the sequential analysis must be confirmed by other techniques. We are currently interested in the isolation and characterization of the enzymes implicated in this hypothetical pathway, i.e., the hydroxylating enzyme system (11) showed that PRT is unstable in the presence of amino acids, tryptamine, and blue cheese extracts. The chloroform extract of the mycelium could contain various amino acids which could react with the aldehyde group of the molecule. Extraction procedures to be used for the detection of substrates naturally contaminated by PRT must take into account this important fact. 
